COR Q4 2022 Earnings — Cencora, Inc. Revenue & Financial Results | Market Cap Arena

CORCencora, Inc.

$69B

Q4 2022 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$61.2B+3.8% YoY

Gross Profit

$1.8B3.0% margin

Operating Income

$552M0.9% margin

Net Income

$295M0.5% margin

EPS (Diluted)

$1.40

QoQ Revenue Growth

+1.8%

Cash Flow

Operating Cash Flow

$1.2B

Free Cash Flow

$991M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$56.6B

Total Liabilities

$56.5B

Stockholders' Equity

-$212M

Cash & Equivalents

$3.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$61.2B	$58.9B	+3.8%
Gross Profit	$1.8B	$1.9B	-3.0%
Operating Income	$552M	$655M	-15.7%
Net Income	$295M	$438M	-32.7%

Revenue Segments

Pharmaceutical Distribution

$207.3B98%

Animal Health

$4.8B2%

Geographic Segments

U.S. Healthcare Solutions

$212.1B100%